Qizhou Lian
- Genetics top 0.1%
- Mesenchymal stem cell research 40
- Cancer Research top 1%
- MicroRNA in disease regulation 7
- Molecular Biology top 1%
- Pluripotent Stem Cells Research 14
- CRISPR and Genetic Engineering 7
- Mitochondrial Function and Pathology 7
- ATP Synthase and ATPases Research 6
- Surgery top 1%
- Tissue Engineering and Regenerative Medicine 17
- Rehabilitation top 1%
-
- Neonatal Respiratory Health Research 6
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Qizhou Lian
119 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Genetics 3.2k
- Cancer Research 1.1k
- Molecular Biology 4.5k
- Surgery 2.1k
- Rehabilitation 310
Countries citing papers authored by Qizhou Lian
This map shows the geographic impact of Qizhou Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qizhou Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qizhou Lian more than expected).
Fields of papers citing papers by Qizhou Lian
This network shows the impact of papers produced by Qizhou Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qizhou Lian. The network helps show where Qizhou Lian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qizhou Lian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 46 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 19 | |
| 7 | Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?breakdown → | 2022 | 349 |
| 8 | 2022 | 41 | |
| 9 | 2022 | 41 | |
| 10 | 2022 | 29 | |
| 11 | 2021 | 88 | |
| 12 | 2017 | 20 | |
| 13 | 2017 | 38 | |
| 14 | 2015 | 45 | |
| 15 | 2015 | 28 | |
| 16 | 2014 | 4 | |
| 17 | 2014 | 237 | |
| 18 | 2013 | 1 | |
| 19 | 2010 | 38 | |
| 20 | 2004 | 18 |
About Qizhou Lian
Qizhou Lian is a scholar working on Genetics, Cancer Research and Immunology, having authored 123 papers that have together received 8.0k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (40 papers), Tissue Engineering and Regenerative Medicine (17 papers), Pluripotent Stem Cells Research (14 papers), CRISPR and Genetic Engineering (7 papers), Mitochondrial Function and Pathology (7 papers), MicroRNA in disease regulation (7 papers), ATP Synthase and ATPases Research (6 papers) and Neonatal Respiratory Health Research (6 papers). The work is most often cited by research in Genetics (3.2k citations), Cancer Research (1.1k citations) and Molecular Biology (4.5k citations). Qizhou Lian has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Hung‐Fat Tse, Yuelin Zhang, Xiaoting Liang, Yue Ding, Hung‐Fat Tse, Fei Gao, Z. Zhang, L. Chen, Jinqiu Zhang and Qing‐Ling Fu. Their work appears in journals such as Cell Death and Disease, Stem Cells, Theranostics, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.